What's new

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 10, Status: Authorised

Mar 27, 2025 - 11:40
 0
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

Dacia to reveal next stage of reinvention plan in November

Next Article

Human medicines European public assessment report (EPAR): Ontozry, cenobamate, D...

Related Posts

EMEA-001213-PIP03-23

EMEA-001213-PIP03-23

Mar 13, 2025  0

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 11, 2025  0

Addendum to the Guideline on clinical development of va...

Feb 27, 2025  0